Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant hits » significant units (Expand Search), significant bias (Expand Search), significant bit (Expand Search)
significant ns » significant bins (Expand Search), significant non (Expand Search), significant new (Expand Search)
Showing 1 - 4 results of 4 for search '(( significant decrease decrease ) OR ( ((significant ns) OR (significant hits)) decrease ))~', query time: 0.36s Refine Results
  1. 1
    Targeting of Vps34 reduces B16F10 tumor growth and working model for Vps34-dependent regulation of eTreg transitional heterogeneity and maintenance.

    Targeting of Vps34 reduces B16F10 tumor growth and working model for Vps34-dependent regulation of eTreg transitional heterogeneity and maintenance. by Erienne G. Norton (9612079)

    Published 2025
    Save to List
    Saved in:
  2. 2
    Alternative representation of daunorubicin fluorescence testing of novel inhibitors.

    Alternative representation of daunorubicin fluorescence testing of novel inhibitors. by Lauren A. McCormick (20540638)

    Published 2025
    Save to List
    Saved in:
  3. 3
    TgHCF101 is involved in Fe-S cluster biogenesis of the CIA pathway.

    TgHCF101 is involved in Fe-S cluster biogenesis of the CIA pathway. by Eléa A. Renaud (18192764)

    Published 2025
    “…Cut-offs were set at ≤1.5- or ≥1.5-fold change (FC) and <i>p</i>-value ≤0.05. Significant hits corresponding to predicted Fe-S cluster proteins are highlighted in red on the graph. …”
    Save to List
    Saved in:
  4. 4
    supplementary figure: Osimertinib inhibits the MYLK4-mediated phosphorylation of CDKAL1 to suppress stemness and chemoresistance in rhabdomyosarcoma

    supplementary figure: Osimertinib inhibits the MYLK4-mediated phosphorylation of CDKAL1 to suppress stemness and chemoresistance in rhabdomyosarcoma by Takuto Itano (16830105)

    Published 2025
    “…The RT‒PCR data are presented as the means ± SDs (n = 3). Statistical significance: ns, p ≥ 0.05. (right): Self-renewal capacity (n = 4) of RD cells treated with osimertinib. …”
    Save to List
    Saved in:

Search Tools: